$3.34
0.144.37%
At close: -
$3.21
-0.13-3.89%
After Hours: 6:03 PM EDT
Comments
Loading...
Xeris Biopharma Holdings (NASDAQ:XERS) Stock, Earnings Estimates, EPS, And Revenue
Xeris Biopharma Holdings reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 5
EPS Estimate
$-0.080
Quarterly Revenue Estimate
$53.27M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$187.36M
Analyze the earnings history of Xeris Biopharma Holdings using advanced sorting and filters.
Data brought to you by Benzinga APIs
Xeris Biopharma Holdings (XERS) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-08 | $-0.11 | $-0.09 | -22.2 % |
| Q2 | 2024-08-08 | $-0.10 | $-0.11 | 9.09 % |
| Q1 | 2024-05-09 | $-0.14 | $-0.12 | -16.7 % |
| Q4 | 2024-03-06 | $-0.10 | $-0.10 | 0.00 % |
Xeris Biopharma Holdings (XERS) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-08 | $54.27M | $51.43M | 5.52 % |
| Q2 | 2024-08-08 | $46.51M | $45.81M | 1.53 % |
| Q1 | 2024-05-09 | $40.64M | $41.81M | -2.80 % |
| Q4 | 2024-03-06 | $44.39M | $43.55M | 1.93 % |
FAQ
When is Xeris Biopharma Holdings (NASDAQ:XERS) reporting earnings?
Xeris Biopharma Holdings (XERS) is scheduled to report earnings on March 5, 2025. The last reported earnings were for reported on November 8, 2024 for Q3.
What were the latest earnings per share (EPS) for Xeris Biopharma Holdings (NASDAQ:XERS)?
The Actual EPS was $-0.11, which missed the estimate of $-0.09.
What were Xeris Biopharma Holdings’s (NASDAQ:XERS) revenues?
The Actual Revenue was $54.3M, which beat the estimate of $51.4M.
Browse earnings estimates, EPS, and revenue on all stocks.